{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:31:05Z","timestamp":1791959465541,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejim.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T14:01:07Z","timestamp":1499090467000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Patent foramen ovale closure to prevent secondary neurologic events"],"prefix":"10.1016","volume":"44","author":[{"given":"Rosie","family":"Jasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Blankenship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejim.2017.06.015_bb0005","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.06.015_bb0010","series-title":"Langman's medical embryology","author":"Sadler","year":"2010"},{"issue":"2","key":"10.1016\/j.ejim.2017.06.015_bb0015","first-page":"1","article-title":"Defining the morphologic phenotypes of atrial septal defects and interatrial communications","volume":"5","author":"McCarthy","year":"2003","journal-title":"Images Paediatr Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2017.06.015_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2017.06.015_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/qjmed\/os-23.90.135","article-title":"Paradoxical embolism","author":"Thompson","year":"1930","journal-title":"QJM"},{"issue":"1038","key":"10.1016\/j.ejim.2017.06.015_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/postgradmedj-2011-130368","article-title":"Diagnosis and management of patent foramen ovale","volume":"88","author":"Buchholz","year":"2012","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.ejim.2017.06.015_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/japplphysiol.00137.2004","article-title":"Exercise-induced intrapulmonary arteriovenous shunting in healthy humans","volume":"97","author":"Eldridge","year":"2004","journal-title":"J Appl Physiol"},{"issue":"14","key":"10.1016\/j.ejim.2017.06.015_bb0040","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0002-9149(96)00163-4","article-title":"Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings","volume":"77","author":"Schneider","year":"1996","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2017.06.015_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/WNL.62.9.1468","article-title":"Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Assessment: transcranial doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"62","author":"Sloan","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejim.2017.06.015_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2214\/ajr.184.1.01840234","article-title":"Diagnosis of patent foramen ovale using contrast-enhanced dynamic MRI: a pilot study","volume":"184","author":"Mohrs","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ejim.2017.06.015_bb0055","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2214\/AJR.06.0489","article-title":"Dynamic contrast-enhanced MRI before and after transcatheter occlusion of patent foramen ovale","volume":"188","author":"Mohrs","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"2\u20133","key":"10.1016\/j.ejim.2017.06.015_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000075790","article-title":"Right-to-left-shunts detected by transesophageal echocardiography and transcranial doppler sonography","volume":"17","author":"Droste","year":"2004","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1526-4610.2006.00433.x","article-title":"Patent foramen ovale and migraine\u2014bringing closure to the subject","volume":"46","author":"Schwedt","year":"2006","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ccd.22232","article-title":"Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing?","volume":"75","author":"Butera","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0075","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.06.015_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"issue":"15_S","key":"10.1016\/j.ejim.2017.06.015_bb0085","article-title":"TCT-30 PREMIUM trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER\u00ae PFO occluder as a treatment for migraine with or without aura","volume":"66","author":"Tobis","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0090","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.758748","article-title":"Migraine intervention with STARFlex technology trial: a controversial trial of migraine and patent foramen ovale closure","volume":"117","author":"Carroll","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ejim.2017.06.015_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-139-9-200311040-00010","article-title":"Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review","volume":"139","author":"Khairy","year":"2003","journal-title":"Ann Intern Med"},{"issue":"7082","key":"10.1016\/j.ejim.2017.06.015_bb0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bmj.314.7082.701","article-title":"Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale","volume":"314","author":"Knauth","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejim.2017.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1152\/jappl.1998.84.5.1622","article-title":"Patent foramen ovale and decompression sickness in sports divers","volume":"84","author":"Germonpre","year":"1998","journal-title":"J Appl Physiol"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2013.12.199","article-title":"Effect of catheter-based patent foramen ovale closure on the occurrence of arterial bubbles in scuba divers","volume":"7","author":"Honek","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ejim.2017.06.015_bb0115","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ehj.2004.04.028","article-title":"Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale","volume":"25","author":"Torti","year":"2004","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2017.06.015_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.amjcard.2013.06.022","article-title":"Effectiveness of percutaneous closure of patent foramen ovale for hypoxemia","volume":"112","author":"Fenster","year":"2013","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcin.2012.01.011","article-title":"Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure","volume":"5","author":"Devendra","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2017.06.015_bb0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/hrt.26.4.549","article-title":"Paradoxical embolism","volume":"26","author":"Corrin","year":"1964","journal-title":"Br Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0135","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(85)80449-6","article-title":"Impending paradoxical embolism from atrial thrombus: correct diagnosis by transesophageal echocardiography and prevention by surgery","volume":"5","author":"Nellessen","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.410250410","article-title":"Infarcts of undetermined cause: the NINCDS stroke data bank","volume":"25","author":"Sacco","year":"1989","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","article-title":"Patent foramen ovale and stroke","volume":"112","author":"Homma","year":"2005","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ejim.2017.06.015_bb0150","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2017.06.015_bb0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-117-6-461","article-title":"Patent foramen ovale as a risk factor for cryptogenic stroke","volume":"117","author":"Di Tullio","year":"1992","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0160","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","article-title":"Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?","volume":"40","author":"Alsheikh-Ali","year":"2009","journal-title":"Stroke"},{"issue":"18","key":"10.1016\/j.ejim.2017.06.015_bb0165","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2017.06.015_bb0170","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.STR.29.5.944","article-title":"Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke","volume":"29","author":"Steiner","year":"1998","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.ejim.2017.06.015_bb0175","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","article-title":"Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies","volume":"55","author":"Overell","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2017.06.015_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1745-6215-12-185","article-title":"The risk of paradoxical embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke","volume":"12","author":"Kent","year":"2011","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.ejim.2017.06.015_bb0190","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ejim.2017.06.015_bb0195","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in cryptogenic stroke study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.112.000658","article-title":"Secondary prevention of atherothrombotic or cryptogenic stroke","volume":"129","author":"Tai","year":"2014","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejim.2017.06.015_bb0205","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/CIRCULATIONAHA.113.005462","article-title":"Contemporary approach to paradoxical embolism","volume":"129","author":"Nayor","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2017.06.015_bb0210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/STROKEAHA.111.631648","article-title":"Patent foramen ovale closure and medical treatments for secondary stroke prevention: A systematic review of observational and randomized evidence","volume":"43","author":"Kitsios","year":"2012","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0220","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejim.2017.06.015_bb0225","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","article-title":"Comparison of three patent foramen ovale closure devices in a randomized trial (amplatzer versus CardioSEAL-STARflex versus helex occluder)","volume":"101","author":"Taaffe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.06.015_bb0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1745-6215-12-56","article-title":"Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO occluder with medical treatment in patients with cryptogenic embolism (PC-trial): rationale and design","volume":"12","author":"Khattab","year":"2011","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.ejim.2017.06.015_bb0235","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ejim.2017.06.015_bb0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ejim.2017.06.015_bb0245","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0250","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","article-title":"Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials","volume":"22","author":"Nagaraja","year":"2013","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0255","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","article-title":"Percutaneous closure of patent foramen ovale for cryptogenic stroke: A meta-analysis of randomized controlled trials","volume":"168","author":"JSW","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2017.06.015_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0265","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"},{"issue":"1\u20132","key":"10.1016\/j.ejim.2017.06.015_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2013.11.027","article-title":"A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack","volume":"337","author":"Chen","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2017.06.015_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: A meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"10.1016\/j.ejim.2017.06.015_bb0280","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","article-title":"Stroke prevention by percutaneous closure of patent foramen ovale: A systematic review and meta-analysis","volume":"100","author":"Wolfrum","year":"2014","journal-title":"Heart"},{"issue":"43","key":"10.1016\/j.ejim.2017.06.015_bb0285","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","article-title":"Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Rengifo-Moreno","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2017.06.015_bb0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","article-title":"Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Hakeem","year":"2013","journal-title":"Cardiovasc Revascul Med"},{"issue":"6","key":"10.1016\/j.ejim.2017.06.015_bb0295","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ccd.25122","article-title":"A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events","volume":"82","author":"Pineda","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ejim.2017.06.015_bb0300","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2017.06.015_bb0305","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.113.001773","article-title":"Potentially large yet uncertain benefits: meta-analysis of patent foramen ovale closure trials","volume":"44","author":"Kitsios","year":"2013","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0310","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association\/American stroke association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0315","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.WNL.0000119173.15878.F3","article-title":"Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the quality standards subcommittee of the American academy of neurology","volume":"62","author":"Messe","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ejim.2017.06.015_bb0320","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"26","key":"10.1016\/j.ejim.2017.06.015_bb0325","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ejim.2017.06.015_bb0330","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0335","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ccd.24875","article-title":"Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies","volume":"82","author":"Abaci","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2017.06.015_bb0340","series-title":"FDA approves new device for prevention of recurrent strokes in certain patients","author":"News Release","year":"2017"},{"issue":"6","key":"10.1016\/j.ejim.2017.06.015_bb0345","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ccd.25794","article-title":"Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective","volume":"85","author":"Singh","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2017.06.015_bb0350","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2007.05.006","volume":"50","author":"King","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2017.06.015_bb0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky","year":"2015","journal-title":"Eur Heart J"},{"issue":"Suppl. 10","key":"10.1016\/j.ejim.2017.06.015_bb0360","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00001888-199410000-00042","article-title":"Outcome bias and cognitive dissonance in evaluating treatment decisions","volume":"69","author":"Gruppen","year":"1994","journal-title":"Acad Med"},{"issue":"2","key":"10.1016\/j.ejim.2017.06.015_bb0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2753.2001.00284.x","article-title":"Rationality in medical decision making: a review of the literature on doctors' decision-making biases","volume":"7","author":"Bornstein","year":"2001","journal-title":"J Eval Clin Pract"},{"issue":"12","key":"10.1016\/j.ejim.2017.06.015_bb0370","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2017.06.015_bb0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.04.063","article-title":"Paradoxical embolism","volume":"64","author":"Windecker","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2017.06.015_bb0380","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jcin.2013.06.013","article-title":"Long-term experience and outcomes with transcatheter closure of patent foramen ovale","volume":"6","author":"Inglessis","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.ejim.2017.06.015_bb0385","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcin.2009.05.010","article-title":"Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: An alternative concurrent mechanism for arterial embolism?","volume":"2","author":"Rigatelli","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ejim.2017.06.015_bb0390","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2010.05.013","article-title":"Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale","volume":"3","author":"Wohrle","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2017.06.015_bb0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jval.2012.08.2208","article-title":"The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy","volume":"16","author":"Jia","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.ejim.2017.06.015_bb0400","article-title":"PFO occluder for cryptogenic stroke recommended by FDA panel","author":"Fornell","year":"2016","journal-title":"DAC Diagn Interv Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T05:48:25Z","timestamp":1719294505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517302595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":80,"alternative-id":["S0953620517302595"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent foramen ovale closure to prevent secondary neurologic events","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}